PLoS ONE (Jan 2015)

Socio-Economic and Clinical Factors as Predictors of Disease Evolution and Acute Events in COPD Patients.

  • Paolo Pandolfi,
  • Alessandro Zanasi,
  • Muriel Assunta Musti,
  • Elisa Stivanello,
  • Lara Pisani,
  • Sabrina Angelini,
  • Francesca Maffei,
  • Silvana Hrelia,
  • Cristina Angeloni,
  • Corrado Zenesini,
  • Patrizia Hrelia

DOI
https://doi.org/10.1371/journal.pone.0135116
Journal volume & issue
Vol. 10, no. 8
p. e0135116

Abstract

Read online

Socio-economic, cultural and environmental factors are becoming increasingly important determinants of chronic obstructive pulmonary disease (COPD). We conducted a study to investigate socio-demographic, lifestyle and clinical factors, and to assess their role as predictors of acute events (mortality or hospitalization for respiratory causes) in a group of COPD patients.Subjects were recruited among outpatients who were undertaking respiratory function tests at the Pneumology Unit of the Sant'Orsola-Malpighi Hospital, Bologna. Patients were classified according to the GOLD Guidelines.229 patients with COPD were included in the study, 44 with Mild, 68 Moderate, 52 Severe and 65 Very Severe COPD (GOLD stage). Significant differences among COPD stage, in terms of smoking status and fragility index, were detected. COPD stage significantly affected the values of all clinical tests (spirometry and ABG analysis). Kaplan-Meier estimates showed a significant difference between survival curves by COPD stage with lower event-free probability in very severe COPD stage. Significant risk factors for acute events were: underweight (HR = 4.08; 95% CI 1.01-16.54), having two or more comorbidities (HR = 4.71; 95% CI 2.52-8.83), belonging to moderate (HR = 3.50; 95% CI 1.01-12.18) or very severe COPD stage (HR = 8.23; 95% CI 2.35-28.85).Our findings indicate that fragility is associated with COPD stage and that comorbidities and the low body mass index are predictors of mortality or hospitalization. Besides spirometric analyses, FeNO measure and comorbidities, body mass index could also be considered in the management and monitoring of COPD patients.